Please login to the form below

Not currently logged in
Email:
Password:

BIA

This page shows the latest BIA news and features for those working in and with pharma, biotech and healthcare.

UK announces new ten-year Life Sciences Vision to support life sciences sector

UK announces new ten-year Life Sciences Vision to support life sciences sector

fund Mubadala to invest £800m in UK life sciences,” said Steve Bates, chief executive of the BioIndustry Association (BIA).

Latest news

  • The key to unlocking inclusivity is continual learning The key to unlocking inclusivity is continual learning

    To help address such fears, we have organised global and regional opportunities for broader learning and understanding in the form of unconscious bias and inclusivity in leadership training.

  • Be careful what you wish for Be careful what you wish for

    And don’t fall for the invincibility bias that once you’ve contracted COVID-19, you can’t get it again (that has been disproven) or that if you do get

  • Diversity and inclusion Diversity and inclusion

    have ever shown unconscious bias or have failed to recognise or challenge scenarios that lacked diversity and inclusion.

  • Chancellor’s ‘coronavirus budget’ also pledges big R&D gains Chancellor’s ‘coronavirus budget’ also pledges big R&D gains

    The BioIndustry Association (BIA) is also delighted with the announcement of an extra £22bn a year for R&D, which means “the £200m life sciences scale up fund now becomes a ... The BIA also welcomed funding for a new railway station – Cambridge

  • It’s Brexit day – now comes the really hard stuff It’s Brexit day – now comes the really hard stuff

    run by UK trade body the BioIndustry Association (BIA) yesterday. ... Michael Warren, who covers Brexit and trade issues for the BIA, said that there’s been no change to the industry position on the negotiation phase for the trade deal.

More from news
Approximately 27 fully matching, plus 192 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 49 partially matching documents found.

Latest appointments

  • Dr David Chiswell joins Kymab Dr David Chiswell joins Kymab

    He has also previously served as chairman of the UK BioIndustry Association (BIA) and was awarded the OBE in 2006 for services to the biotechnology industry.

  • Jane Osbourn to chair BIA board Jane Osbourn to chair BIA board

    VP of R&D atMedimmune to chair BioIndustry Association board. Jane Osbourn will be the new chair of the BioIndustry Associaton (BIA) board, effective January 2016. ... She said: “It has been my privilege to serve as a member of the BIA board since

  • ABPI names first project director for manufacturing ABPI names first project director for manufacturing

    ABPI and the BioIndustry Association (BIA) established the MMIP in September this year to create a suitable environment for medicines manufacturing.

  • UCB’s Mark Bodmer elected to BIA board UCB’s Mark Bodmer elected to BIA board

    Will hold the position for a three-year fixed term. UCB's Mark Bodmer has been elected to the board of UK trade body the BioIndustry Association (BIA). ... As a board member of the BIA Bodmer will play a role in shaping the policy environment of the UK

  • BIA elects six new board members BIA elects six new board members

    Biotech trade body adds representatives from MedImmune, J&J and more. UK trade body the BioIndustry Association (BIA) has elected six new members to its board. ... The BIA also announced several returning board members, including John Brown of Vectura

More from appointments
Approximately 4 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 33 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Innovative Trials

Innovative Trials specialises in delivering effective global patient recruitment strategies for your clinical trials by adopting a patient and site-centric...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...